Forbion

Forbion, founded in 2006, is a prominent global venture capital firm based in The Netherlands with a focus on the biotech sector. With a deep-rooted expertise in Europe, Forbion has established itself as a formidable player in the venture capital landscape, managing just over €5 billion across various fund strategies.

Leveraging its robust knowledge in biotech, Forbion invests in innovative companies that are on the cutting edge of (bio-) pharmaceutical drug development. The firm's extensive reach and financial resources allow it to capture opportunities across all stages of drug development, positioning itself as a critical partner for biotech ventures.

Additionally, through its BioEconomy fund strategy, Forbion extends its expertise beyond human health challenges to address pressing planetary health issues by investing in companies working on sustainable solutions in food, agriculture, materials, and environmental technology sectors. This strategic diversification not only broadens its investment horizon but also contributes to sustainable innovations crucial for our future.